| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.11e-08 | 18 | 106 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.42e-07 | 28 | 106 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.46e-06 | 37 | 106 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase (ATP) activity | 2.79e-05 | 2 | 106 | 2 | GO:0004781 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase activity | 2.79e-05 | 2 | 106 | 2 | GO:0004779 | |
| GeneOntologyMolecularFunction | adenylylsulfate kinase activity | 2.79e-05 | 2 | 106 | 2 | GO:0004020 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.53e-05 | 70 | 106 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 DNAH10 IQCA1L MLH3 DNAH12 GNB5 ABCB8 GNB4 AGAP7P GNB2 AGAP4 DNAH9 AGAP6 DNAH11 | 6.05e-05 | 775 | 106 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 DNAH10 IQCA1L MLH3 DNAH12 GNB5 ABCB8 GNB4 AGAP7P GNB2 AGAP4 DNAH9 AGAP6 DNAH11 | 1.40e-04 | 839 | 106 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 DNAH10 IQCA1L MLH3 DNAH12 GNB5 ABCB8 GNB4 AGAP7P GNB2 AGAP4 DNAH9 AGAP6 DNAH11 | 1.42e-04 | 840 | 106 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 DNAH10 IQCA1L MLH3 DNAH12 GNB5 ABCB8 GNB4 AGAP7P GNB2 AGAP4 DNAH9 AGAP6 DNAH11 | 1.42e-04 | 840 | 106 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 2.76e-04 | 5 | 106 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | KALRN NTRK2 PAPSS2 PAPSS1 TAOK2 JAK3 MTOR KDR TAOK1 ATM ALK EPHA1 | 3.81e-04 | 709 | 106 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.96e-04 | 65 | 106 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.17e-04 | 118 | 106 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | enzyme activator activity | CTSC TOM1L1 TSC2 TAOK2 TBC1D16 GNB5 TAOK1 AGAP7P AGAP4 AGAP6 ALK | 7.28e-04 | 656 | 106 | 11 | GO:0008047 |
| GeneOntologyMolecularFunction | kinase activity | KALRN NTRK2 PAPSS2 PAPSS1 TAOK2 JAK3 MTOR KDR TAOK1 ATM ALK EPHA1 | 7.38e-04 | 764 | 106 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.06e-03 | 145 | 106 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.09e-03 | 85 | 106 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.34e-03 | 600 | 106 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | KALRN NTRK2 POLH PAPSS2 PAPSS1 TAOK2 JAK3 MTOR KDR TAOK1 ATM ALK EPHA1 | 1.39e-03 | 938 | 106 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.52e-03 | 507 | 106 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.52e-03 | 507 | 106 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 DNAH10 TMEM94 IQCA1L MLH3 DNAH12 ABCB8 ACSM6 DNAH9 DNAH11 | 1.58e-03 | 614 | 106 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.78e-03 | 12 | 106 | 2 | GO:0008239 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.43e-03 | 441 | 106 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 2.96e-03 | 54 | 106 | 3 | GO:0030159 | |
| GeneOntologyBiologicalProcess | response to hypoxia | 1.79e-06 | 348 | 106 | 11 | GO:0001666 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.73e-06 | 228 | 106 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 2.77e-06 | 364 | 106 | 11 | GO:0036293 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 8.96e-06 | 335 | 106 | 10 | GO:0043087 | |
| GeneOntologyBiologicalProcess | response to oxygen levels | 1.34e-05 | 430 | 106 | 11 | GO:0070482 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 2.62e-05 | 2 | 106 | 2 | GO:0050428 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate biosynthetic process | 2.62e-05 | 2 | 106 | 2 | GO:0034036 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 3.80e-05 | 244 | 106 | 8 | GO:0043547 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | KALRN NTRK2 TOM1L1 TSC2 DIPK2A EPM2AIP1 TAOK2 TBC1D16 MTOR GNB5 KDR AGAP7P AGAP4 AGAP6 ALK EPHA1 | 6.96e-05 | 1028 | 106 | 16 | GO:0043085 |
| GeneOntologyBiologicalProcess | short-chain fatty acid transport | 7.82e-05 | 3 | 106 | 2 | GO:0015912 | |
| GeneOntologyBiologicalProcess | sulfate assimilation | 1.56e-04 | 4 | 106 | 2 | GO:0000103 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.28e-06 | 25 | 106 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 7.91e-06 | 54 | 106 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 9.48e-06 | 56 | 106 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.48e-05 | 10 | 106 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.27e-05 | 230 | 106 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.13e-04 | 238 | 106 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | axoneme | 6.58e-04 | 207 | 106 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 6.70e-04 | 137 | 106 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.74e-04 | 208 | 106 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 7.37e-04 | 35 | 106 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | cell body | KALRN ADAM21 NTRK2 SMURF1 TSC2 MTOR GNB5 SORCS2 KDR GNB4 GNB2 SLC7A10 ALK | 8.43e-04 | 929 | 106 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.14e-03 | 230 | 106 | 6 | GO:0098562 | |
| GeneOntologyCellularComponent | GTPase complex | 1.17e-03 | 41 | 106 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.38e-03 | 161 | 106 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | side of membrane | ADAM21 RYR2 EPM2AIP1 JAK3 IGHG4 CD36 GNB5 PKHD1 KDR GNB4 RAET1L GNB2 | 1.60e-03 | 875 | 106 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | motile cilium | 2.22e-03 | 355 | 106 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.53e-03 | 185 | 106 | 5 | GO:0009898 | |
| Domain | Dynein_heavy_chain_D4_dom | 9.81e-09 | 14 | 105 | 5 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 9.81e-09 | 14 | 105 | 5 | IPR013602 | |
| Domain | DHC_N2 | 9.81e-09 | 14 | 105 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 9.81e-09 | 14 | 105 | 5 | IPR011704 | |
| Domain | AAA_8 | 9.81e-09 | 14 | 105 | 5 | PF12780 | |
| Domain | AAA_5 | 9.81e-09 | 14 | 105 | 5 | PF07728 | |
| Domain | DHC_fam | 1.46e-08 | 15 | 105 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 1.46e-08 | 15 | 105 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.46e-08 | 15 | 105 | 5 | IPR004273 | |
| Domain | Dynein_HC_stalk | 9.04e-07 | 14 | 105 | 4 | IPR024743 | |
| Domain | MT | 9.04e-07 | 14 | 105 | 4 | PF12777 | |
| Domain | Guanine_nucleotide-bd_bsu | 1.71e-06 | 5 | 105 | 3 | IPR016346 | |
| Domain | DHC_N1 | 9.47e-06 | 8 | 105 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.47e-06 | 8 | 105 | 3 | IPR013594 | |
| Domain | Gprotein_B | 2.01e-05 | 10 | 105 | 3 | IPR001632 | |
| Domain | Sulfurylase_cat_dom | 3.13e-05 | 2 | 105 | 2 | IPR024951 | |
| Domain | ATP-sulfurylase | 3.13e-05 | 2 | 105 | 2 | PF01747 | |
| Domain | PUA_2 | 3.13e-05 | 2 | 105 | 2 | PF14306 | |
| Domain | APS_kinase | 3.13e-05 | 2 | 105 | 2 | IPR002891 | |
| Domain | Sulphate_adenylyltransferase | 3.13e-05 | 2 | 105 | 2 | IPR002650 | |
| Domain | ATP-Sase_PUA-like_dom | 3.13e-05 | 2 | 105 | 2 | IPR025980 | |
| Domain | Tyr_kinase_cat_dom | 1.38e-04 | 88 | 105 | 5 | IPR020635 | |
| Domain | TyrKc | 1.38e-04 | 88 | 105 | 5 | SM00219 | |
| Domain | AAA | 1.63e-04 | 144 | 105 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.63e-04 | 144 | 105 | 6 | IPR003593 | |
| Domain | PROTEIN_KINASE_TYR | 2.18e-04 | 97 | 105 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.18e-04 | 97 | 105 | 5 | IPR008266 | |
| Domain | FATC | 3.10e-04 | 5 | 105 | 2 | PF02260 | |
| Domain | FAT | 4.63e-04 | 6 | 105 | 2 | PS51189 | |
| Domain | FATC | 4.63e-04 | 6 | 105 | 2 | PS51190 | |
| Domain | FAT | 4.63e-04 | 6 | 105 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 4.63e-04 | 6 | 105 | 2 | IPR003151 | |
| Domain | FATC_dom | 4.63e-04 | 6 | 105 | 2 | IPR003152 | |
| Domain | PIK_FAT | 4.63e-04 | 6 | 105 | 2 | IPR014009 | |
| Domain | FATC | 4.63e-04 | 6 | 105 | 2 | SM01343 | |
| Domain | ArfGap | 5.67e-04 | 29 | 105 | 3 | SM00105 | |
| Domain | ARFGAP | 5.67e-04 | 29 | 105 | 3 | PS50115 | |
| Domain | ArfGap | 5.67e-04 | 29 | 105 | 3 | PF01412 | |
| Domain | ArfGAP | 5.67e-04 | 29 | 105 | 3 | IPR001164 | |
| Domain | Pkinase_Tyr | 8.09e-04 | 129 | 105 | 5 | PF07714 | |
| Domain | Kinase-like_dom | 9.53e-04 | 542 | 105 | 10 | IPR011009 | |
| Domain | - | 9.91e-04 | 35 | 105 | 3 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 1.08e-03 | 36 | 105 | 3 | IPR015422 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.09e-03 | 138 | 105 | 5 | IPR001245 | |
| Domain | Protein_kinase_ATP_BS | 1.35e-03 | 379 | 105 | 8 | IPR017441 | |
| Domain | G-protein_beta_WD-40_rep | 1.35e-03 | 85 | 105 | 4 | IPR020472 | |
| Domain | SPRY | 1.47e-03 | 87 | 105 | 4 | SM00449 | |
| Domain | PyrdxlP-dep_Trfase | 1.58e-03 | 41 | 105 | 3 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 1.58e-03 | 41 | 105 | 3 | IPR015421 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.67e-03 | 11 | 105 | 2 | IPR002011 | |
| Domain | SPRY | 1.95e-03 | 94 | 105 | 4 | PF00622 | |
| Domain | SPRY_dom | 1.95e-03 | 94 | 105 | 4 | IPR003877 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.99e-03 | 12 | 105 | 2 | PS00239 | |
| Domain | B30.2/SPRY | 2.03e-03 | 95 | 105 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.03e-03 | 95 | 105 | 4 | PS50188 | |
| Domain | PP2C_SIG | 2.73e-03 | 14 | 105 | 2 | SM00331 | |
| Domain | PI3/4_kinase_CS | 3.13e-03 | 15 | 105 | 2 | IPR018936 | |
| Domain | PPM_1 | 3.13e-03 | 15 | 105 | 2 | PS01032 | |
| Domain | - | 3.57e-03 | 16 | 105 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.57e-03 | 16 | 105 | 2 | SM00146 | |
| Domain | Aminotran_1_2 | 4.03e-03 | 17 | 105 | 2 | PF00155 | |
| Domain | PP2C | 4.03e-03 | 17 | 105 | 2 | IPR015655 | |
| Domain | Aminotransferase_I/II | 4.03e-03 | 17 | 105 | 2 | IPR004839 | |
| Domain | PROTEIN_KINASE_ATP | 4.37e-03 | 459 | 105 | 8 | PS00107 | |
| Domain | Ig_I-set | 4.39e-03 | 190 | 105 | 5 | IPR013098 | |
| Domain | I-set | 4.39e-03 | 190 | 105 | 5 | PF07679 | |
| Domain | PI3_PI4_kinase | 4.52e-03 | 18 | 105 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 4.52e-03 | 18 | 105 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.52e-03 | 18 | 105 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 4.52e-03 | 18 | 105 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 4.52e-03 | 18 | 105 | 2 | PS50290 | |
| Domain | PP2C | 5.03e-03 | 19 | 105 | 2 | PF00481 | |
| Domain | PUA-like_domain | 5.03e-03 | 19 | 105 | 2 | IPR015947 | |
| Domain | PP2Cc | 5.57e-03 | 20 | 105 | 2 | SM00332 | |
| Domain | - | 5.57e-03 | 20 | 105 | 2 | 3.60.40.10 | |
| Domain | PPM-type_phosphatase_dom | 5.57e-03 | 20 | 105 | 2 | IPR001932 | |
| Domain | PPM_2 | 5.57e-03 | 20 | 105 | 2 | PS51746 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.04e-07 | 27 | 81 | 5 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.48e-06 | 43 | 81 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.64e-06 | 45 | 81 | 5 | M47670 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 9.85e-06 | 24 | 81 | 4 | M47460 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.37e-05 | 26 | 81 | 4 | M47456 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 3.65e-05 | 33 | 81 | 4 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 3.65e-05 | 33 | 81 | 4 | M10322 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.66e-04 | 19 | 81 | 3 | MM15021 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.66e-04 | 19 | 81 | 3 | M926 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.94e-04 | 20 | 81 | 3 | MM15572 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.94e-04 | 20 | 81 | 3 | M27853 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 2.03e-04 | 94 | 81 | 5 | M797 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.26e-04 | 21 | 81 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.26e-04 | 21 | 81 | 3 | MM15159 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.60e-04 | 22 | 81 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.60e-04 | 22 | 81 | 3 | M841 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.98e-04 | 23 | 81 | 3 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 2.98e-04 | 23 | 81 | 3 | M47549 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M48987 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 3.39e-04 | 24 | 81 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 3.39e-04 | 24 | 81 | 3 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 3.39e-04 | 24 | 81 | 3 | M18308 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 3.39e-04 | 24 | 81 | 3 | MM14794 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 3.84e-04 | 25 | 81 | 3 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 3.84e-04 | 25 | 81 | 3 | M811 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 3.84e-04 | 25 | 81 | 3 | M14301 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.86e-04 | 60 | 81 | 4 | MM14964 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.12e-04 | 61 | 81 | 4 | MM15071 | |
| Pathway | WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES | 4.32e-04 | 26 | 81 | 3 | M48054 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 4.32e-04 | 26 | 81 | 3 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 4.32e-04 | 26 | 81 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 4.32e-04 | 26 | 81 | 3 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 4.32e-04 | 26 | 81 | 3 | M47557 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 4.32e-04 | 26 | 81 | 3 | M20 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 4.82e-04 | 6 | 81 | 2 | MM14679 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 4.82e-04 | 6 | 81 | 2 | M27027 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 4.84e-04 | 27 | 81 | 3 | M47454 | |
| Pathway | REACTOME_GPER1_SIGNALING | 4.84e-04 | 27 | 81 | 3 | MM15664 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 4.90e-04 | 174 | 81 | 6 | M48058 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 5.40e-04 | 28 | 81 | 3 | M10679 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 6.00e-04 | 29 | 81 | 3 | M47466 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 6.63e-04 | 30 | 81 | 3 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 6.63e-04 | 30 | 81 | 3 | MM14542 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.20e-04 | 339 | 81 | 8 | M39736 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 7.32e-04 | 31 | 81 | 3 | MM15094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 7.32e-04 | 31 | 81 | 3 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 7.32e-04 | 31 | 81 | 3 | M47455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 7.32e-04 | 31 | 81 | 3 | M47459 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 7.32e-04 | 31 | 81 | 3 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 7.32e-04 | 31 | 81 | 3 | M47541 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 7.74e-04 | 72 | 81 | 4 | MM14631 | |
| Pathway | WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS | 8.04e-04 | 32 | 81 | 3 | M48055 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 8.04e-04 | 32 | 81 | 3 | M861 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 8.04e-04 | 32 | 81 | 3 | M14309 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 8.04e-04 | 32 | 81 | 3 | MM15148 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 8.04e-04 | 32 | 81 | 3 | MM15143 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 8.04e-04 | 32 | 81 | 3 | M47962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 8.04e-04 | 32 | 81 | 3 | MM14983 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 8.81e-04 | 33 | 81 | 3 | M39532 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 8.81e-04 | 33 | 81 | 3 | MM15027 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.81e-04 | 33 | 81 | 3 | MM15020 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 8.81e-04 | 33 | 81 | 3 | MM15058 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 8.81e-04 | 33 | 81 | 3 | M47550 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.81e-04 | 33 | 81 | 3 | M9379 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 8.93e-04 | 8 | 81 | 2 | MM1576 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 8.93e-04 | 8 | 81 | 2 | M22063 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 9.96e-04 | 77 | 81 | 4 | MM15044 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.04e-03 | 78 | 81 | 4 | M1921 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.05e-03 | 35 | 81 | 3 | M1075 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.14e-03 | 36 | 81 | 3 | MM14544 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.15e-03 | 80 | 81 | 4 | M800 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 1.33e-03 | 38 | 81 | 3 | M27656 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.38e-03 | 143 | 81 | 5 | MM15055 | |
| Pathway | WP_OVARIAN_INFERTILITY | 1.44e-03 | 39 | 81 | 3 | M39458 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 1.44e-03 | 39 | 81 | 3 | MM15003 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.55e-03 | 40 | 81 | 3 | MM15115 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.73e-03 | 302 | 81 | 7 | M39719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY | 1.73e-03 | 11 | 81 | 2 | M47915 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.79e-03 | 42 | 81 | 3 | M791 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.91e-03 | 43 | 81 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.91e-03 | 43 | 81 | 3 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.91e-03 | 43 | 81 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.04e-03 | 44 | 81 | 3 | MM15709 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.09e-03 | 157 | 81 | 5 | M4904 | |
| Pathway | REACTOME_CA2_PATHWAY | 2.18e-03 | 45 | 81 | 3 | MM15040 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.18e-03 | 45 | 81 | 3 | M45008 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 2.44e-03 | 13 | 81 | 2 | M47603 | |
| Pathway | KEGG_SULFUR_METABOLISM | 2.44e-03 | 13 | 81 | 2 | M18256 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 2.47e-03 | 47 | 81 | 3 | M39518 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.62e-03 | 48 | 81 | 3 | M10775 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 2.95e-03 | 50 | 81 | 3 | M39822 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 3.26e-03 | 15 | 81 | 2 | M47663 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 3.30e-03 | 52 | 81 | 3 | M920 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.45e-03 | 108 | 81 | 4 | M17034 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 3.53e-03 | 343 | 81 | 7 | MM15712 | |
| Pathway | WP_RAS_SIGNALING | 4.13e-03 | 184 | 81 | 5 | M39764 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 4.19e-03 | 17 | 81 | 2 | M39483 | |
| Pathway | PID_SHP2_PATHWAY | 4.28e-03 | 57 | 81 | 3 | M100 | |
| Pubmed | ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. | 2.91e-08 | 3 | 108 | 3 | 20160076 | |
| Pubmed | 8.59e-08 | 14 | 108 | 4 | 9373155 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 11175280 | ||
| Pubmed | Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. | 5.78e-07 | 6 | 108 | 3 | 23878245 | |
| Pubmed | Ranking novel cancer driving synthetic lethal gene pairs using TCGA data. | 5.78e-07 | 6 | 108 | 3 | 27438146 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 16884933 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 9256245 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 24462769 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.41e-06 | 9 | 108 | 3 | 12640130 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 10339615 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 3.44e-06 | 10 | 108 | 3 | 20664521 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 3.44e-06 | 10 | 108 | 3 | 28334111 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 9733924 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 10644457 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 34932372 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 4.72e-06 | 11 | 108 | 3 | 15381706 | |
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 4.72e-06 | 11 | 108 | 3 | 25982117 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 15854902 | ||
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 6.28e-06 | 12 | 108 | 3 | 20186915 | |
| Pubmed | Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers. | 6.28e-06 | 12 | 108 | 3 | 16301321 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 8636150 | ||
| Pubmed | 6.30e-06 | 83 | 108 | 5 | 11114734 | ||
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 27713690 | ||
| Pubmed | A member of a family of sulfate-activating enzymes causes murine brachymorphism. | 9.55e-06 | 2 | 108 | 2 | 9671738 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25228590 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15985311 | ||
| Pubmed | Loss of TSC2 confers resistance to ceramide and nutrient deprivation. | 9.55e-06 | 2 | 108 | 2 | 23604129 | |
| Pubmed | Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. | 9.55e-06 | 2 | 108 | 2 | 11850821 | |
| Pubmed | SorCS2 is required for BDNF-dependent plasticity in the hippocampus. | 9.55e-06 | 2 | 108 | 2 | 27457814 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10657990 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10679223 | ||
| Pubmed | mTORC2 is required for proliferation and survival of TSC2-null cells. | 9.55e-06 | 2 | 108 | 2 | 21482669 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11931637 | ||
| Pubmed | Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma. | 9.55e-06 | 2 | 108 | 2 | 16153455 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23699409 | ||
| Pubmed | TSC2 regulates VEGF through mTOR-dependent and -independent pathways. | 9.55e-06 | 2 | 108 | 2 | 12957289 | |
| Pubmed | Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis. | 9.55e-06 | 2 | 108 | 2 | 24591652 | |
| Pubmed | Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25. | 9.55e-06 | 2 | 108 | 2 | 11597335 | |
| Pubmed | Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm. | 9.55e-06 | 2 | 108 | 2 | 22242175 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34667149 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28336152 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29364507 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29518389 | ||
| Pubmed | Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. | 9.55e-06 | 2 | 108 | 2 | 22287548 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25972538 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22492229 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21886784 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27023784 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9771708 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35665929 | ||
| Pubmed | USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines. | 9.55e-06 | 2 | 108 | 2 | 32578360 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28830982 | ||
| Pubmed | Pancreatic β-cell failure mediated by mTORC1 hyperactivity and autophagic impairment. | 9.55e-06 | 2 | 108 | 2 | 24740570 | |
| Pubmed | 1.03e-05 | 14 | 108 | 3 | 22453919 | ||
| Pubmed | 1.92e-05 | 17 | 108 | 3 | 19376773 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17562867 | ||
| Pubmed | Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity. | 2.86e-05 | 3 | 108 | 2 | 30926242 | |
| Pubmed | Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities. | 2.86e-05 | 3 | 108 | 2 | 30926243 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35240013 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15624760 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 32646003 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17018601 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 29056426 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26831717 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 32091432 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35099634 | ||
| Pubmed | Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway. | 2.86e-05 | 3 | 108 | 2 | 26735435 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23878397 | ||
| Pubmed | Nutrient signaling in protein homeostasis: an increase in quantity at the expense of quality. | 2.86e-05 | 3 | 108 | 2 | 23592839 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23348097 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23966835 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24952635 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 36227673 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17071493 | ||
| Pubmed | Placental mTOR complex 1 regulates fetal programming of obesity and insulin resistance in mice. | 2.86e-05 | 3 | 108 | 2 | 34032632 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20615870 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23508953 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25878330 | ||
| Pubmed | [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma]. | 2.86e-05 | 3 | 108 | 2 | 19176054 | |
| Pubmed | The E3 Ligases Spsb1 and Spsb4 Regulate RevErbα Degradation and Circadian Period. | 2.86e-05 | 3 | 108 | 2 | 31607207 | |
| Pubmed | Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. | 2.86e-05 | 3 | 108 | 2 | 9786855 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11675383 | ||
| Pubmed | TAO kinases mediate activation of p38 in response to DNA damage. | 2.86e-05 | 3 | 108 | 2 | 17396146 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28289099 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 36715448 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18926585 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 34611268 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22362778 | ||
| Pubmed | SIRT1 negatively regulates the mammalian target of rapamycin. | 2.86e-05 | 3 | 108 | 2 | 20169165 | |
| Pubmed | Pml represses tumour progression through inhibition of mTOR. | 2.86e-05 | 3 | 108 | 2 | 21387562 | |
| Pubmed | Selective association of G protein beta(4) with gamma(5) and gamma(12) subunits in bovine tissues. | 2.86e-05 | 3 | 108 | 2 | 10409705 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18342602 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 29131570 | ||
| Pubmed | Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. | 2.86e-05 | 3 | 108 | 2 | 25155956 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23585562 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37449548 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37462942 | ||
| Pubmed | Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. | 2.86e-05 | 3 | 108 | 2 | 26742086 | |
| Pubmed | Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. | 2.86e-05 | 3 | 108 | 2 | 18568033 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21641396 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 4.39e-04 | 149 | 108 | 4 | chr2p23 | |
| Cytoband | 2p23.3 | 5.68e-04 | 68 | 108 | 3 | 2p23.3 | |
| GeneFamily | Dyneins, axonemal | 5.18e-09 | 17 | 72 | 5 | 536 | |
| GeneFamily | ArfGAPs | 3.03e-04 | 33 | 72 | 3 | 395 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.55e-04 | 161 | 72 | 5 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.38e-04 | 40 | 72 | 3 | 321 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 2.05e-03 | 17 | 72 | 2 | 701 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.05e-03 | 17 | 72 | 2 | 1291 | |
| GeneFamily | Ankyrin repeat domain containing | 2.78e-03 | 242 | 72 | 5 | 403 | |
| GeneFamily | Fibronectin type III domain containing | 3.81e-03 | 160 | 72 | 4 | 555 | |
| GeneFamily | WD repeat domain containing | 3.91e-03 | 262 | 72 | 5 | 362 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.07e-03 | 163 | 72 | 4 | 590 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.08e-03 | 24 | 72 | 2 | 654 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.80e-03 | 394 | 72 | 6 | 471 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.16e-02 | 41 | 72 | 2 | 102 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-08 | 184 | 108 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-08 | 184 | 108 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-08 | 184 | 108 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-07 | 169 | 108 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-07 | 178 | 108 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.12e-07 | 182 | 108 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.12e-07 | 182 | 108 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.48e-07 | 185 | 108 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-07 | 185 | 108 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.48e-07 | 185 | 108 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.48e-07 | 185 | 108 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.48e-07 | 185 | 108 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.88e-07 | 188 | 108 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.03e-07 | 189 | 108 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 4.32e-07 | 191 | 108 | 7 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.80e-07 | 194 | 108 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.80e-07 | 194 | 108 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.97e-07 | 195 | 108 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.97e-07 | 195 | 108 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.97e-07 | 195 | 108 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.87e-06 | 151 | 108 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-06 | 169 | 108 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 169 | 108 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.10e-06 | 173 | 108 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-06 | 174 | 108 | 6 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 177 | 108 | 6 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 177 | 108 | 6 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 177 | 108 | 6 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.83e-06 | 178 | 108 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 179 | 108 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.31e-06 | 181 | 108 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 182 | 108 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 182 | 108 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 182 | 108 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-06 | 183 | 108 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-06 | 183 | 108 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.84e-06 | 184 | 108 | 6 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.84e-06 | 184 | 108 | 6 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.84e-06 | 184 | 108 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.21e-06 | 186 | 108 | 6 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.21e-06 | 186 | 108 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-06 | 186 | 108 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.21e-06 | 186 | 108 | 6 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-06 | 186 | 108 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 187 | 108 | 6 | 051b8c07d7489ce7576f6c57ce7008767ef76869 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 187 | 108 | 6 | 888856cde7a69ea2f14d590597e25b1af6383c51 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.40e-06 | 187 | 108 | 6 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 6.60e-06 | 188 | 108 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 6.60e-06 | 188 | 108 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-06 | 188 | 108 | 6 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.81e-06 | 189 | 108 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.81e-06 | 189 | 108 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 6.81e-06 | 189 | 108 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.81e-06 | 189 | 108 | 6 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 6.81e-06 | 189 | 108 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.81e-06 | 189 | 108 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.81e-06 | 189 | 108 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.81e-06 | 189 | 108 | 6 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 7.01e-06 | 190 | 108 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.01e-06 | 190 | 108 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.01e-06 | 190 | 108 | 6 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.01e-06 | 190 | 108 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.23e-06 | 191 | 108 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.23e-06 | 191 | 108 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.23e-06 | 191 | 108 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.23e-06 | 191 | 108 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.23e-06 | 191 | 108 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.23e-06 | 191 | 108 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.23e-06 | 191 | 108 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.23e-06 | 191 | 108 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.23e-06 | 191 | 108 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 110 | 108 | 5 | 3a641dced828ed97a8eea70d0a7b76f33630c9be | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.45e-06 | 192 | 108 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.45e-06 | 192 | 108 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.45e-06 | 192 | 108 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.45e-06 | 192 | 108 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.67e-06 | 193 | 108 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.67e-06 | 193 | 108 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.67e-06 | 193 | 108 | 6 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.67e-06 | 193 | 108 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.67e-06 | 193 | 108 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-06 | 194 | 108 | 6 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 195 | 108 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 195 | 108 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 195 | 108 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| Disease | cerebral palsy (implicated_via_orthology) | 5.01e-06 | 10 | 104 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | DNAH3 KALRN CAPN6 SLC22A9 MLH3 GNB5 PKHD1 KDR GNB4 LGR6 KDM6A EPHA1 | 7.03e-06 | 702 | 104 | 12 | C0009402 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.46e-05 | 148 | 104 | 6 | C0279702 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.88e-05 | 15 | 104 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.88e-05 | 15 | 104 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.88e-05 | 15 | 104 | 3 | C0154091 | |
| Disease | Carcinoma of bladder | 3.34e-05 | 18 | 104 | 3 | C0699885 | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIb | 3.68e-05 | 3 | 104 | 2 | C1846389 | |
| Disease | FOCAL CORTICAL DYSPLASIA OF TAYLOR | 3.68e-05 | 3 | 104 | 2 | C1846385 | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIa | 3.68e-05 | 3 | 104 | 2 | C1846386 | |
| Disease | Isolated focal cortical dysplasia type II | 3.68e-05 | 3 | 104 | 2 | cv:C1846385 | |
| Disease | FOCAL CORTICAL DYSPLASIA, TYPE II | 3.68e-05 | 3 | 104 | 2 | 607341 | |
| Disease | schizophrenia (implicated_via_orthology) | 9.97e-05 | 68 | 104 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.31e-04 | 28 | 104 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | female breast cancer (is_implicated_in) | 3.40e-04 | 8 | 104 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | bitter beverage consumption measurement | 4.42e-04 | 42 | 104 | 3 | EFO_0010089 | |
| Disease | Colorectal Neoplasms | 4.56e-04 | 277 | 104 | 6 | C0009404 | |
| Disease | heparin-binding egf-like growth factor measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0020438 | |
| Disease | immature platelet count | 5.49e-04 | 106 | 104 | 4 | EFO_0803544 | |
| Disease | immature platelet fraction | 7.22e-04 | 114 | 104 | 4 | EFO_0009187 | |
| Disease | immature platelet measurement | 8.47e-04 | 119 | 104 | 4 | EFO_0803541 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 8.77e-04 | 53 | 104 | 3 | C1961099 | |
| Disease | colorectal cancer (is_implicated_in) | 9.02e-04 | 121 | 104 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Crohn's disease | 9.72e-04 | 441 | 104 | 7 | EFO_0000384 | |
| Disease | alcohol use disorder measurement | 9.84e-04 | 214 | 104 | 5 | EFO_0009458 | |
| Disease | thalamus volume change measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0021496 | |
| Disease | Malignant Neoplasms | 1.11e-03 | 128 | 104 | 4 | C0006826 | |
| Disease | X-17654 measurement | 1.25e-03 | 15 | 104 | 2 | EFO_0800784 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.43e-03 | 16 | 104 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.43e-03 | 16 | 104 | 2 | C0334634 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.43e-03 | 16 | 104 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | diacylglycerol 44:7 measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0020069 | |
| Disease | Malignant neoplasm of breast | 1.44e-03 | 1074 | 104 | 11 | C0006142 | |
| Disease | Bladder Neoplasm | 1.55e-03 | 140 | 104 | 4 | C0005695 | |
| Disease | susceptibility to vaginal yeast infection measurement | 1.59e-03 | 65 | 104 | 3 | EFO_0008412 | |
| Disease | Malignant neoplasm of urinary bladder | 1.59e-03 | 141 | 104 | 4 | C0005684 | |
| Disease | magnesium measurement | 1.66e-03 | 66 | 104 | 3 | EFO_0004845 | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.66e-03 | 66 | 104 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | sphingosine 1-phosphate measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0800185 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.02e-03 | 19 | 104 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.02e-03 | 19 | 104 | 2 | C2936783 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.09e-03 | 152 | 104 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | electroencephalogram measurement | 2.30e-03 | 74 | 104 | 3 | EFO_0004357 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.30e-03 | 74 | 104 | 3 | DOID:3748 (is_marker_for) | |
| Disease | behavioural disinhibition measurement | 2.39e-03 | 75 | 104 | 3 | EFO_0006946 | |
| Disease | cancer (implicated_via_orthology) | 2.64e-03 | 268 | 104 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | complex trait | 2.77e-03 | 271 | 104 | 5 | EFO_0010578 | |
| Disease | Immunologic Deficiency Syndromes | 2.97e-03 | 23 | 104 | 2 | C0021051 | |
| Disease | cortical thickness change measurement, age at assessment | 2.97e-03 | 23 | 104 | 2 | EFO_0008007, EFO_0021501 | |
| Disease | Coronary heart disease | 3.23e-03 | 24 | 104 | 2 | C0010068 | |
| Disease | West Syndrome | 3.23e-03 | 24 | 104 | 2 | C0037769 | |
| Disease | Lynch syndrome (is_implicated_in) | 3.23e-03 | 24 | 104 | 2 | DOID:3883 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPHMVSWEEYASARG | 431 | Q6P461 | |
| IWYGVDVMARDAHGN | 621 | Q96P64 | |
| LYWDCLLMRGHEITE | 241 | P54793 | |
| YQDCPMQGRRDTDHW | 66 | P21709 | |
| TQDYIWHKGMRCESI | 401 | O95196 | |
| WHKGMRCESIITDFQ | 406 | O95196 | |
| ESMTHWGQELCFVVY | 481 | Q9NS82 | |
| NGVTCWGIDYHLRMN | 586 | Q9UKJ8 | |
| WGIDYHLRMNISDIG | 591 | Q9UKJ8 | |
| AYRVCMTNEGHPWVS | 36 | Q8NHS2 | |
| HALGMVDSRENCWKF | 2956 | Q96DT5 | |
| WDVCMERGHRDLEQF | 1066 | Q6XZF7 | |
| RHWYSDMRTGECQGL | 251 | Q96MC9 | |
| ASEWLLRCGAMVRYH | 66 | Q99766 | |
| LRCGAMVRYHGQERW | 71 | Q99766 | |
| MEQHFLGCVKRAWDS | 1 | Q3ZCQ2 | |
| IWYGVDVMARDAHGN | 621 | Q5VW22 | |
| VMWAAACGHGAVLEF | 121 | C9JTQ0 | |
| HVYMWGQCRGQSVIL | 306 | Q8NDN9 | |
| WDMRSGQCVQAFETH | 266 | O14775 | |
| DMLWSGSRGCETHAF | 1096 | P52333 | |
| MRDWIAACQLHGGLE | 101 | Q8N6L0 | |
| GLYCRDQAHAERWAM | 26 | Q6IWH7 | |
| MCDELVAEMEHYGQW | 576 | O60568 | |
| TEVQWHCRSRMIAGA | 491 | O95340 | |
| ENAWNRSHSEGLMCR | 181 | Q3ZCV2 | |
| MTDLREEDSGHYWCR | 96 | O95944 | |
| FEVWNAMTRGQHCDT | 76 | Q6JVE5 | |
| AMTRGQHCDTWSYVL | 81 | Q6JVE5 | |
| GDFEAVWDCAMVRHV | 761 | Q9HBX8 | |
| HQVSDWMEQEGRRCL | 851 | Q5JYT7 | |
| HAAAWMDLGTLYESC | 351 | O15550 | |
| IWMYNCHIGGSFSEE | 741 | Q9Y4K0 | |
| CSDWQRHFDVALGRM | 1041 | Q9UHC1 | |
| AWRCHVNQMLSDTDG | 2686 | O94915 | |
| AAQGWRARMEDAHCT | 71 | Q8N819 | |
| HECLETYLWEMTSGV | 1301 | O60229 | |
| PQWIHYTMVRLDCED | 461 | Q6ZR08 | |
| ASMLIGDHYLCDVTW | 291 | P27487 | |
| WDVRDSMCRQTFIGH | 211 | P62879 | |
| WDIRDGMCRQSFTGH | 211 | Q9HAV0 | |
| LYDRSWMVVNHNGVC | 611 | Q96EN8 | |
| VSVWCSNDYLGMSRH | 191 | P22557 | |
| AMGMYQELHRWDECI | 711 | Q9UG01 | |
| CHHMRGNQLWEYDAE | 496 | Q8IUC8 | |
| VWPGAMALCQYLEEH | 91 | Q5VZV1 | |
| MYAGPTEVQWHCRAR | 496 | O43252 | |
| TEVQWHCRARMVAGA | 501 | O43252 | |
| WCGLQDVYQMTEGRH | 46 | Q9Y2L6 | |
| INCLLSGEEHDMWVF | 2471 | Q13315 | |
| SGEEHDMWVFRLCSL | 2476 | Q13315 | |
| MGCWSIEHVEQYLGT | 1891 | Q9ULT8 | |
| LHQVEMEDAGMYWCR | 896 | Q93033 | |
| LYGCFDQVSHEWMDG | 1756 | Q8TD57 | |
| QWLCDFGFLVDIMEH | 376 | Q7L775 | |
| LSYWESHCDMINGTD | 236 | P16671 | |
| MAWCRENIDTSHGDV | 246 | Q10981 | |
| CGRMVAVNYVGEELW | 236 | Q8NDZ4 | |
| TYCNETMTGWVHDVL | 116 | P53634 | |
| EAINRDFHSCLGWMQ | 91 | Q5U5Z8 | |
| IWYGVDVMARDAHGN | 621 | Q5VUJ5 | |
| MEVQDCHRAGVCLRW | 651 | Q86VF2 | |
| RWQEGNVFSCSVMHE | 296 | P01861 | |
| AYIHGLFMEGACWDT | 4396 | Q9NYC9 | |
| GEFWMSLEDFCRNFH | 321 | Q9Y6Q1 | |
| VEITKHFVRWMNGSC | 926 | Q8IVF4 | |
| HRFNETQPCDMGWEY | 101 | Q9Y226 | |
| HYGRSWQAGDVVGCM | 1151 | Q92736 | |
| ICVDWRHGSRAMYTQ | 121 | P54317 | |
| ECMWVTVGLYLQEGH | 71 | Q96FM1 | |
| AHCIVVMADGRVWEA | 676 | Q9NUT2 | |
| MRCLEALGEWGQLHQ | 1481 | P42345 | |
| HCWLNAFAEMLRFGD | 386 | P35610 | |
| DWGQFMHICDIINTT | 31 | O75674 | |
| MSGQLERCEREWHEL | 1 | A0PK00 | |
| MLENFTAFIPGHRCW | 36 | Q8IVM8 | |
| IPMICAGHEEYLNTW | 391 | A6NCM1 | |
| MHRLCAAGEWNQVGA | 66 | Q9Y2N7 | |
| RVVCGHCGNTFLWME | 151 | Q8N4L2 | |
| DDHEFMVIACDGIWN | 431 | O15355 | |
| KEEMYITSDCGHTWR | 541 | Q96PQ0 | |
| LREHTAWLVMEYCLG | 96 | Q7L7X3 | |
| LREHTAWLVMEYCLG | 96 | Q9UL54 | |
| TCTEMRYISWEAIHG | 2271 | P08F94 | |
| SWLYAMCRGIEHDPV | 296 | Q9Y253 | |
| VQLHVDEAWRLGCMA | 616 | Q5JTZ9 | |
| GGVAREWLYLLCHEM | 441 | Q9HCE7 | |
| EQGRMVWHVAAYEGL | 576 | Q9UM73 | |
| GTADRCWLHLDQGFM | 491 | Q9BY15 | |
| MGQCLRYQMHWEDLE | 1 | A0PJX0 | |
| AMNFAIGCVVRAHQW | 66 | P51800 | |
| EVYELMLGCWQREPH | 781 | Q16620 | |
| MQDRIDDNGWGCAYR | 291 | Q9NUQ7 | |
| DGAHAVVICTEWDMF | 406 | O60701 | |
| MVWTIARIHFEDYGC | 271 | P32241 | |
| CWTEGHMTYGNDVVL | 151 | P0DPA2 | |
| MWHPNIYETGDVCIS | 81 | P49427 | |
| HYGSWEMITGDEIQI | 226 | Q9BZQ8 | |
| EAVSSQEMLRCIWGH | 371 | Q12767 | |
| VWGHCEVTMRYINGL | 216 | Q96A44 | |
| VWGHCEIRMRYLNGL | 216 | Q96BD6 | |
| MGGYEINHLLWHCVA | 256 | C9JQI7 | |
| SLGEDGLQMLFCHRW | 596 | Q8TBP0 | |
| HQWSACESGFLLGMD | 321 | Q6U7Q0 | |
| RNRWCSYLGQEMEPH | 986 | Q9UHP3 | |
| MVRSAEHCWYFGEVF | 81 | Q96RJ0 | |
| SFHYISMGDCIGWLE | 181 | Q5VY80 | |
| DAIEVMRNHWCSYLG | 1001 | Q96RU2 | |
| MRNHWCSYLGQDIAE | 1006 | Q96RU2 | |
| MGGSVQCWREEAYEA | 296 | Q9BRX9 | |
| FALITALVCWHGMED | 61 | Q9BWM5 | |
| MLGHYTDACTEIWRQ | 311 | Q8N3Z6 | |
| MWHPNIYENGDVCIS | 81 | Q712K3 | |
| YQTMLDCWHGEPSQR | 1136 | P35968 | |
| IDSGCHYWEVVMGSS | 586 | Q9UJV3 | |
| VRHCEAMETRGQWAQ | 381 | Q6BDS2 | |
| GEDGQFTYCWHDDIM | 1601 | P49815 | |
| CGRLYEDQEEWMSHG | 1041 | Q9C0D4 |